Literature DB >> 14665720

High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

Decio Armanini1, Davide Nacamulli, Carla Scaroni, Franco Lumachi, Riccardo Selice, Cristina Fiore, Gennaro Favia, Franco Mantero.   

Abstract

The study was performed to evaluate the prevalence of thyroid abnormalities detected by ultrasonography and, in particular, of multinodular nontoxic goiter in primary aldosteronism. We analyzed 80 consecutive of patients with primary hyperaldosteronism (40 with unilateral adenoma and 40 with idiopathic hyperaldosteronism) and 80 normotensive healthy controls, comparable for age, sex, iodine intake, and geographical area. Blood pressure, thyroid palpation, thyroid function, and ultrasonography were evaluated. The prevalence of ultrasonographic thyroid abnormalities was 60% in primary aldosteronism and 27% in controls (p < 0.0001). There was a statistically significant difference in prevalence of these abnormalities in unilateral adenoma and idiopathic hyperaldosteronism with respect to controls (p < 0.05 and p < 0.0001, respectively). The prevalence of multinodular nontoxic goiter in idiopathic hyperaldosteronism was higher than in controls (p < 0.001) and, in particular, in female patients. From these data it seems to be worth considering the existence of primary hyperaldosteronism in patients with multinodular goiter and hypertension.

Entities:  

Mesh:

Year:  2003        PMID: 14665720     DOI: 10.1385/ENDO:22:2:155

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  20 in total

Review 1.  Growth factors and goitrogenesis.

Authors:  S P Bidey; D J Hill; M C Eggo
Journal:  J Endocrinol       Date:  1999-03       Impact factor: 4.286

Review 2.  Adrenocortical tumors: recent advances in basic concepts and clinical management.

Authors:  S R Bornstein; C A Stratakis; G P Chrousos
Journal:  Ann Intern Med       Date:  1999-05-04       Impact factor: 25.391

3.  Demonstration of nodules in the normal thyroid by echography.

Authors:  J Woestyn; M Afschrift; K Schelstraete; A Vermeulen
Journal:  Br J Radiol       Date:  1985-12       Impact factor: 3.039

4.  Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus.

Authors:  A Beckers; R Abs; P J Willems; B van der Auwera; K Kovacs; M Reznik; A Stevenaert
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

5.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

6.  Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status.

Authors:  N Knudsen; I Bülow; T Jorgensen; P Laurberg; L Ovesen; H Perrild
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

7.  Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up.

Authors:  T Rago; L Chiovato; F Aghini-Lombardi; L Grasso; A Pinchera; P Vitti
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

8.  Regulation of the HGF-receptor c-met in the thyroid gland.

Authors:  K M Schulte; G Antoch; M Ellrichmann; M Finken-Eigen; K Köhrer; D Simon; P E Goretzki; H D Röher
Journal:  Exp Clin Endocrinol Diabetes       Date:  1998       Impact factor: 2.949

9.  Thyroid gland: US screening in a random adult population.

Authors:  A Brander; P Viikinkoski; J Nickels; L Kivisaari
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

10.  Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.

Authors:  F Mantero; G Opocher; M Boscaro; E Valpione; D Armanini; F Fallo
Journal:  Horm Metab Res       Date:  1981-08       Impact factor: 2.936

View more
  4 in total

1.  Association of primary aldosteronism with chronic thyroiditis.

Authors:  Chiara Sabbadin; Caterina Mian; Davide Nacamulli; Gabriella Donà; Fabio Presotto; Corrado Betterle; Marco Boscaro; Luciana Bordin; Decio Armanini
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence-A Case Report and Review of the Literature.

Authors:  S S C Gunatilake; U Bulugahapitiya
Journal:  Case Rep Endocrinol       Date:  2017-10-30

3.  The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease.

Authors:  Laura Handgriff; Christian Adolf; Daniel A Heinrich; Leah Braun; Nina Nirschl; Lisa Sturm; Roland Ladurner; Jens Ricke; Max Seidensticker; Martin Bidlingmaier; Martin Reincke
Journal:  Horm Metab Res       Date:  2020-05-13       Impact factor: 2.936

4.  Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.

Authors:  Shigenori Nakamura; Masatoshi Ishimori; Noriyoshi Yamakita
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.